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Recent studies have reported the relationship 
between periodontal diseases and many systemic 
disorders such as cardiovascular diseases, diabetes, 
pulmonary diseases, cancers, and neonatal malfor-
mations prior to child birth. The rationale for these 
problems would probably be related to chronic and 
long-term aspects of inflammation in periodontal 
diseases.1,2
Porphyromonas gingivalis is an anaerobic gram 
negative bacterium which resides in the mouth and 
is highly associated with periodontal diseases.3 
Since this bacterium has a high genetic capability 
to develop resistance against any unfavorable 
interventional condition against its proliferation; it 
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Abstract
It seems that Porphyromanas gingivalis is carcinogenic, because it activates a number of inflammatory immune responses 
in the host and causes disorders in bacterial clearance mechanisms. There is little information on the prevalence of this 
bacterium in cancer patients. The aim of this study was to evaluate and compare the prevalence of P. gingivalis in cancer 
patients by meta-analysis methods.
Different databases including PubMed, EMBASE, the Cochrane Library, Scopus, and ISI web of Knowledge were 
investigated and eight relevant articles published in 2000–2013 were finally analyzed. Data were analyzed by meta-
analysis method, fixed effect model. I² statistics were calculated to examine the heterogeneity of papers. The information 
was analyzed by R and STATA Ver 12.2.
A total of 711 people infected with P. gingivalis were included in this study. In total, the prevalence of P. gingivalis was 
40.7% (95% CI, 19.3–62.1). The prevalence of P. gingivalis was evaluated in four case-control studies. The results of this 
study showed that P. gingivalis increased the chance of cancer development and periodontal disease as much as 1.36 times 
(OR, 1.36; 95%CI, 0.47–3.97).
Although there was no significant correlation between P. gingivalis and cancer, this bacterium increased the chance of 
cancer and periodontal disease and could be considered as a main potential risk factor.
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can also develop resistance against different cur-
rently used antibiotics. Most studies have shown 
that non-surgical attempts to remove P. gingivalis 
have failed due to the special niche of this bacte-
rium (packets deeper than 5 mm).4,5 On the other 
hand, due to the painful outcome of surgical inter-
ventions and higher expenditures associated with 
these kinds of treatment, patients with periodontitis 
do not lean to select surgical treatment and there-
fore finding a non-surgical strategy for treatment 
of these patients is highly important. According to 
the studies from America and Europe, the most 
common antibiotics applied for the control of 
aggressive periodontitis in Iran, were combina-
tions of amoxicillin and metronidazole. However, 
the prevalence of antibiotic resistance against these 
two antibiotics (particularly amoxicillin) is high 
among the Iranian population, due to the common 
prescriptions of these antibiotics by the physi-
cians.5 One of the most important points for antibi-
otic prescription in periodontal diseases is to 
choose narrow spectrum and not commonly used 
antibiotics. Many studies have reported the gas-
trointestinal adverse effects of antibiotic over- 
application.6 It seems that P. gingivalis bacteria 
may be carcinogenic, since it activates some immu-
nologic and inflammatory reactions in the host, 
creating some disturbances in the clearance of bac-
teria.7 P. gingivalis has the capability to invade and 
penetrate different epithelial cells and possesses a 
complex mechanism that enables the bacterium to 
change the cellular defence, particularly, some spe-
cial genes of the host. Some studies have shown 
the effects of P. gingivalis, in different levels, on 
some molecules associated with cellular cycles 
inside the cell. An important carcinogenic effect of 
P. gingivalis is the inhibition of epithelial cells’ 
apoptosis which is an intrinsic protective mecha-
nism of cancerous cells.8,9 This process may be 
created via the prolongation of cell survival and 
increasing of the cell proliferation.10 This bacte-
rium has the ability to invade, proliferate, and sur-
vive inside the cytoplasm of infected cells and, 
thereby, spread to contiguous cells.11 The preva-
lence rate of periodontal bacteria among cancer 
patients may be associated with patients’ health 
status, existence of any oral pathogenic condition, 
time of chemotherapy, surgery, disease stage, type 
of cancer, patients’ age, previous or current antibi-
otic therapy, et cetera.12 Moreover, investigating 
the prevalence rate of periodontal agents such as 
P. gingivalis among cancer patients is important, 
since its findings can help physicians to control 
correlated periodontal complications and have a 
better view for the next treatment planning of can-
cer disease. There are little knowledge about the 
prevalence rate of P. gingivalis among cancer 
patients and this study aims to evaluate and com-
pare the prevalence rate of P. gingivalis among 
cancer patients via a meta-analysis method.
Materials and methods
Search method
Motor searches of PubMed, EMBASE, the 
Cochrane Library, Scopus, and ISI web of 
Knowledge were interrogated to find the correlated 
studies. The key words of periodontal disease, 
Porphyromonas gingivalis bacteria, and cancer 
were used in this search and English language stud-
ies were identified by two independent researchers 
and the relevant studies were selected for evalua-
tion. For a more comprehensive search, the refer-
ences of identified papers were also searched.
Paper selection
First, a list of all the existing titles and paper 
abstracts were identified in the literature by the 
researchers and were evaluated for selection of the 
most correlated articles. Then, all the correlated 
studies were entered into the analysis. Out of the 
57 evaluated studies, 17 were irrelevant or repeated. 
Among the 40 remained papers, 30 were inconsist-
ent with the defined criteria of this study and the 
prevalence rate of the bacteria for two other studies 
were not reported. Finally eight consistent studies 
were selected and entered into the final analysis 
(Figure 1). The correlated information of these 
papers was entered into a prepared check list and 
was entered into the SPSS 16 for meta-analysis 
(Table 1). The criteria for the selection of appropri-
ate papers in this meta-analysis were as follows: 
(1) randomized control trial (RCT) papers; (2) 
case-control studies; (3) the prevalence of P. gingi-
valis; and (4) different kinds of cancers. Repeated 
articles were removed.
Data extraction
Data were extracted according to the following 
markers: (1) methodology of study; (2) type of 
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cancer; (3) prevalence of P. gingivalis in the cases 
and control groups; (4) number of participants in 
each study and either in case or control groups; (5) 
type of sampling; (6) serotypes of P. gingivalis; 
and (7) name of author, year of publication, and the 
studied country. Abstracts and full text of all the 
Figure 1. The flowchart of selected articles for final analysis.











Kang12 2009 Korea 58.0 ± 9.7 Head and neck 
tumors
Saliva 28/52 0.71 (0.51–0.91)
Rajakaruna14 2012 Japan 59 ± 11 Head and neck 
tumors
Lymph node 66/58 0.17 (–0.05–0.39)
Michaud15 2012 10 European 
countries
59 ± 11 Pancreatic cancer Blood 405/416 0.07 (–0.02–0.17)





Ferreira17 2011 Brazil Acute apical 
abscesses
33 0.35 (0.08–0.62)





Alexa19 2012 Netherlands 48.8 ± 13.6 Jaw osteonecrosis Leukemia 49/5 0.20 (0.09–0.31)
Katz20 2011 USA Squamous cell 
carcinoma
10/5 0.33 (0.04–0.62)
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studied papers were evaluated by two of our co-
workers separately and in case of any inconsist-
ency, both authors matched the results together and 
solved the discrepancy.
Statistical analysis
Since the main evaluated marker in this study was 
the prevalence rate of P. gingivalis, its variance 
was measured via binominal distribution and 95% 
confidence interval was considered for this analy-
sis. To combine the different prevalence rates 
reported by papers, their mean weights were 
applied. Each study was dedicated a weight in 
accordance with inverted variance. For evaluation 
of no heterogeneity of data, Q test and I2 marker 
with 10% error level were applied. In four case-
control studies, odds ratio and 95% CI were calcu-
lated. In case of heterogeneity of results, data were 
analyzed using random effect model. Stata version 
11/2 and R version 2/15/1 software were used for 
data analysis and all the P values were reported as 
two-tail figures and P <0.05 was considered as 
significant.
Results
In this meta-analysis, eight consistent studies pub-
lished between 2000 and 2013 were identified and 
entered into the final analysis, to assess the preva-
lence of P. gingivalis among patients suffering 
from periodontal diseases (Figure 1). The total 
prevalence of P. gingivalis was 40.7% (95% CI, 
19.3–62.1) (Figure 2). In four studies, the preva-
lence of P. gingivalis was reported among groups 
of cases and controls (Figure 3). The results of this 
study revealed that this relationship was not statis-
tically significant; however, P. gingivalis increased 
the prevalence of cancer and periodontal diseases, 
most of which consequently resulted in gingival 
cancers; therefore, this bacterium could be consid-
ered as a potent risk factor. In other words, this 
study revealed that P. gingivalis increased the odds 
ratio of cancer and periodontal diseases as much as 
1.36 (OR, 1.36; 95% CI, 0.47–3.97). According to 
the results of the Jamaican study, P. gingivalis 
increased the chance of periodontal diseases by 
6.6-fold, which was statistically significant (OR, 
6.6; 95% CI, 2.57–16.91). The publication bias fig-
ure showed that the bias effect among studies was 
not significant, since most of the studies were 
inside the funnel plot and it can be presumed that 
the results of most correlated studies have been 
entered into this meta-analysis (Figure 4).
Discussion
Periodontal diseases are created by complex func-
tion of a group of anaerobic periodontal bacteria 
which are mostly gram negative.23,24 In the current 
study the relationship between P. gingivalis bacte-
ria and cancer was investigated via meta-analysis 
of relevant papers. The results of this study revealed 
that the prevalence of P. gingivalis among cancer 
patients was significantly higher than healthy indi-
viduals. The results of our study were in accord-
ance with those reported by Kutz and others in 
2011. They reported that P. gingivalis may cause 
mouth cancer and showed that P. gingivalis induced 
the alteration of epithelial cells to neoplastic forms 
and its concentration rate was higher among cancer 
cells than normal tissues of mouth.20 According to 
Kang et al.’s study, there was a significant differ-
ence between the group of head and neck cancer 
patients and group of healthy individuals for the 
frequency of P. gingivalis. Contrary to our results, 
Kang et al.’s study revealed a higher prevalence of 
P. gingivalis among healthy individuals than can-
cer patients (Figure 3). This discrepancy may be 
associated with different conditions such as 
patients’ health status and types of cancer treat-
ment.13 Also, the prevalence of P. gingivalis was 
compared between groups of solid and non-solid 
cancers by Kang et al. and it was revealed that its 
prevalence was higher among non-solid cancers.12
Another study by Michaud and others showed 
that the prevalence rate of pancreatic cancer among 
patients with >200 ng antibody of P. gingivalis was 
two-fold higher than that among those with ⩽200 
ng. This result may support the idea that periodon-
tal diseases increase the risk of pancreatic cancer.15 
Their study also reported that higher serum levels 
of P. gingivalis (ATCC 53978) may be the best 
marker for the higher burden of the bacteria and 
invasive periodontal diseases which may justify 
why this bacterium is the only periodontal patho-
gen possibly correlated with higher risk of pancre-
atic cancer. Also, a recent study compared the 
saliva samples of healthy individuals and those 
with pancreatic cancer patients and reported that 
there was a significant relationship between higher 
prevalence of P. gingivalis and this type of 
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NOTE: Weights are from random effects analysis
































Figure 2. The prevalence rate of P. gingivalis among all selected studies upon random effects model. The middle point of each 
line indicates the prevalence rate and length of line indicates 95% confidence interval of each study. Rhombus shape indicates the 
prevalence rate for all studies.
NOTE: Weights are from random effects analysis





















Figure 3. Relationship between P. gingivalis and cancer and/or periodontal studies among groups of cases and controls and 95% 
CI upon random effects model. The middle point of each line indicates the prevalence rate and the length of line indicates 95% 
confidence interval of each study. Rhombus shape indicates 95% confidence interval for all studies.
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cancer.25 Different studies have investigated the 
possible relationship between mouth’s cancer and 
periodontal diseases26,27 and most of these studies 
have shown the positive relationship between these 
diseases. A study from Jamaica reported a positive 
relationship between the presence of P. gingivalis 
and periodontal diseases and also revealed that P. 
gingivalis was the most potent predictor for perio-
dontal diseases among adolescents,16 which was in 
accordance with our results. The importance of our 
findings about a higher prevalence rate of P. gingi-
valis in cancer tissue compared to healthy tissue is 
not certain; however, this bacterium invades both 
healthy and neoplastic tissues more than other bac-
teria such as S. gordonii. Meanwhile, P. gingivalis 
can intervene in the cancerogenesis process by 
inhibiting the host’s cellar death and induction of 
cell proliferation.
Some carcinogenic properties of P. gingivalis are 
as follows: it attaches to different lines of gingival 
cancer cells;28 invades the epithelial cells of gingiva 
in experimental conditions;29 it prevents and 
restrains apoptosis of epithelial cells;30 it prolifer-
ates and survives in the epithelial cells and spreads 
to other cells;31 it promotes cell survival and 
increases cellular proliferation;32 it induces COX-2 
gene expression;33 and it increases the production 
of TNF-a, IL-6, IL-8, and IL-1b.34 P. gingivalis 
possesses a lipoprotein and LPS on its external sur-
face that can provoke proliferation of human fibro-
blast cells.35
Evidences show that micro-RNA (miRNA) has 
an important role in the incidence of cancer.36 
During the inflammatory responses by mac-
rophages, special types of miRNA are induced 
which have the ability to regulate the host’s cell 
responses against pathogenic agents. Furthermore, 
pathogenic agents themselves may regulate miRNA 
expression. For example, P. gingivalis can induce 
the expression of several miRNA among gingival 
epithelial cells. Totally, miRNA influences intrin-
sic and adaptive immunity control networks as 
well as apoptosis via regulation of signaling path-
ways such as TLR paths,37,38 signaling pathways of 
cytokine37 and Stat 3.39 Recent studies have 
reported that cells can secrete miRNA40 and send it 
to the receiver cells, where it can influence the 
gene expression.41,42 Therefore, there is a probabil-
ity that miRNA, associated with immunity, is 
transferred to neoplastic tissues, even if the patho-
genic agents are located at another place.
There are differences between the prevalence 
rates reported by different studies for P. gingivalis 
that may be associated with the variations of P. gin-
givalis strains used in different studies. There are 
two completely different P. gingivalis strains which 
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Figure 4. Begg’s funnel plot for publication bias in the risk difference (RD) analysis. Each circle represents the RDs for eradication 
success. The diameter of each circle represents the weight in the meta-analysis.
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differ in several aspects. For example, the strain 
P. gingivalis ATCC53978 has a recognized capsule 
as the main antigen associated with pathogenesis43 
and the strain P. gingivalis ATCC33277does not 
have this antigen and, therefore, causes a slight 
inflammation.44,45
There were not enough data associated with age, 
gender, smoking, and alcohol consumption in this 
meta-analysis. These variables are important and 
may impress the ability of bacteria to invade the 
immune system during invasion to tissues and, there-
fore, potentially influence the malignancy process.
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